e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CDT Equity Inc. - Common Stock
(NQ:
CDT
)
0.6350
-0.1018 (-13.82%)
Streaming Delayed Price
Updated: 11:42 AM EDT, Oct 9, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CDT Equity Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 21, 2024
Via
Benzinga
What's Going On With Conduit Pharmaceuticals Shares Today?
November 21, 2024
Conduit Pharmaceuticals Inc. (NASDAQ: CDT) shares are trading higher Thursday after the company announced that the Japan Patent Office granted a composition of matter patent for its lead asset,...
Via
Benzinga
Topics
Intellectual Property
Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders
November 21, 2024
Approval of composition of matter patent in key jurisdiction underscores the Company’s commitment to maximize future out-licensing value
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Why Is Conduit Pharmaceuticals (CDT) Stock Up 12% Today?
August 14, 2024
Conduit Pharmaceuticals stock is up on Wednesday alongside heavy trading following an invest update on CDT shares.
Via
InvestorPlace
Why Is Conduit Pharmaceuticals (CDT) Stock Up 123% Today?
August 08, 2024
Conduit Pharmaceuticals stock is up on Thursday with heavy trading of CDT shares after the company announce a new license agreement.
Via
InvestorPlace
Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors
November 19, 2024
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket
November 11, 2024
Via
Benzinga
Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline
November 04, 2024
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes
November 01, 2024
From
Conduit Pharmaceuticals
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 24, 2024
Via
Benzinga
S&P 500 Moves Higher; BlackRock Reports Upbeat Results
October 11, 2024
Via
Benzinga
Topics
Stocks
Gold Gains 1%; Wells Fargo Shares Gain After Q3 Earnings
October 11, 2024
Via
Benzinga
Dow Surges 150 Points; JPMorgan Posts Upbeat Earnings
October 11, 2024
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 03, 2024
Via
Benzinga
Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket
October 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 02, 2024
Via
Benzinga
Why Zhibao Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
September 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
September 02, 2024
Via
Benzinga
Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
August 28, 2024
From
Conduit Pharmaceuticals
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
August 14, 2024
Pre-market stock movers are a hot topic on Wednesday and we have all of the biggest stories traders need to know about this morning!
Via
InvestorPlace
Why Serve Robotics Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
August 14, 2024
Via
Benzinga
CDT Stock Earnings: Conduit Pharmaceuticals Reported Results for Q2 2024
August 13, 2024
Conduit Pharmaceuticals just reported results for the second quarter of 2024.
Via
InvestorPlace
Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders
August 12, 2024
From
Conduit Pharmaceuticals
Via
GlobeNewswire
S&P 500 Gains 1%; US Jobless Claims Fall To 230,000
August 08, 2024
Via
Benzinga
Topics
Stocks
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
August 08, 2024
It's time to dive into the biggest pre-market stock movers on Thursday morning with all of the latest news this morning!
Via
InvestorPlace
Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments
August 08, 2024
From
Conduit Pharmaceuticals
Via
GlobeNewswire
EXCLUSIVE: Penny Stock Conduit Pharmaceuticals Inks Licensing Pact With AstraZeneca For Multiple Assets
August 08, 2024
Conduit Pharmaceuticals has entered an exclusive licensing agreement with AstraZeneca to develop AZD1656, AZD5658, and AZD5904, targeting autoimmune disorders and idiopathic male infertility. Conduit...
Via
Benzinga
Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
July 17, 2024
Via
Benzinga
What Happened With Conduit Pharmaceuticals (CDT) Stock Today?
July 16, 2024
Conduit Pharmaceuticals shares traded higher by over 50% early Tuesday. The company announced it received patent approval for its lead asset targeting autoimmune diseases.
Via
Benzinga
Topics
Intellectual Property
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
Facebook
Twitter
YouTube